Robert J. Alpern - Sep 30, 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ Robert J. Alpern by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Sep 30, 2025
Transactions value $
$7,769
Form type
4
Date filed
10/2/2025, 04:34 PM
Previous filing
Jul 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Alpern Robert J Director 100 ABBOTT PARK ROAD, ABBOTT PARK /s/ Robert J. Alpern by Jessica H. Paik, Attorney-in-Fact 2025-10-02 0001448074

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Stock Equivalent Units Award $7.77K +58 +0.57% $133.94 10.3K Sep 30, 2025 Common Shares 58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
F2 Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.